UPDATED Apr 16, 2024
Companies with a market cap of more than US$1B, strong financial health, modest PE ratios, past earnings growth and paying a dividend.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
A3M | €4.35 | 0.6% | 16.4% | €979.5m | €4.54 | PE5.7x | E-13.2% | 9.7% | Media | ||
IDR | €18.57 | 1.0% | 46.3% | €3.2b | €21.28 | PE15.7x | E13.1% | 1.3% | Software | ||
VID | €96.20 | 4.5% | 3.3% | €3.1b | €106.50 | PE13.3x | E4.8% | 1.4% | Materials | ||
GEST | €2.87 | -1.7% | -31.8% | €1.6b | €4.42 | PE5.8x | E16.4% | 5.1% | Automobiles | ||
XNOR | Mex$9.95 | -1.5% | 37.2% | Mex$496.6b | Mex$11.46 | PB2x | E7.6% | 3.0% | Banks | ||
APAM | €30.70 | 1.8% | -7.0% | €2.1b | €31.78 | PE10.3x | E20.9% | 6.9% | Materials | ||
CMO | €20.00 | -1.0% | 11.7% | €1.3b | €21.50 | PE8.4x | n/a | 5.2% | Materials | ||
XUSIO | R$1.76 | -3.3% | 17.3% | R$12.1b | R$1.89 | PE9x | E5.9% | 2.8% | Materials | ||
FAE | €3.18 | 0.8% | 2.3% | €988.2m | €3.71 | PE10.8x | E-1.1% | 4.9% | Pharmaceuticals & Biotech |